Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone for Antipsychotic-Induced Weight Gain

NCT01866098 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01866098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01866098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone for Antipsychotic-Induced Weight Gain
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
April 7, 2019
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, schizoaffective disorder, schizophrenia, schizophreniform disorder, severe major depression with psychotic features